Association of magnetic resonance imaging markers of cerebrovascular disease burden and cognition

Stroke

Volumn 46, Issue 10, 2015, Pages 2808-2814

  Xu, Xin ^a,b   Hilal, Saima ^a,b   Collinson, Simon L ^a   Yi Chong, Eddie Jun ^a,b   Ikram, Mohammad Kamran ^a,b   Venketasubramanian, Narayanaswamy ^b,c   Chen, Christopher Li Hsian ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^c RAFFLES HOSPITAL   (Singapore)

Author keywords

Cerebrovascular disorders; Cognition; Magnetic resonance imaging; Stroke

Indexed keywords

AGED; ARTICLE; BRAIN CORTEX; BRAIN HEMORRHAGE; CEREBROVASCULAR DISEASE; COGNITION; COGNITION ASSESSMENT; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODAL IMAGING; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; WHITE MATTER LESION; CASE CONTROL STUDY; COGNITION DISORDERS; COMPLICATION; COMPUTER ASSISTED DIAGNOSIS; MIDDLE AGED; PATHOLOGY; PROCEDURES;

AGED; CASE-CONTROL STUDIES; CEREBROVASCULAR DISORDERS; COGNITION DISORDERS; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROIMAGING; NEUROPSYCHOLOGICAL TESTS;

EID: 84942874535     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.115.010700     Document Type: Article

References (43)

1. Catindig JA, Venketasubramanian N, Ikram MK, Chen C. Epidemiology of dementia in Asia: insights on prevalence, trends and novel risk factors. J Neurol Sci. 2012;321:6-11. doi: 10.1016/j.jns.2012.07.023.
2. Venketasubramanian N, Sahadevan S, Kua EH, Chen CP, Ng TP. Interethnic differences in dementia epidemiology: global and Asia-Pacifc perspectives. Dement Geriatr Cogn Disord. 2010;30:492-498. doi: 10.1159/000321675.
3. Narasimhalu K, Ang S, De Silva DA, Wong MC, Chang HM, Chia KS, et al. Severity of CIND and MCI predict incidence of dementia in an ischemic stroke cohort. Neurology. 2009;73:1866-1872. doi: 10.1212/WNL.0b013e3181c3fcb7.
4. Prins ND, van Dijk EJ, den Heijer T, Vermeer SE, Jolles J, Koudstaal PJ, et al. Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain. 2005;128(pt 9):2034-2041. doi: 10.1093/brain/awh553.
5. Luchsinger JA, Brickman AM, Reitz C, Cho SJ, Schupf N, Manly JJ, et al. Subclinical cerebrovascular disease in mild cognitive impairment. Neurology. 2009;73:450-456. doi: 10.1212/WNL.0b013e3181b1636a.
6. van der Flier WM, van Straaten EC, Barkhof F, Verdelho A, Madureira S, Pantoni L, et al. Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study. Stroke. 2005;36:2116-2120. doi: 10.1161/01.STR.0000179092.59909.42.
7. Huijts M, Duits A, van Oostenbrugge RJ, Kroon AA, de Leeuw PW, Staals J. Accumulation of MRI markers of cerebral small vessel disease is associated with decreased cognitive function. a study in frst-ever lacu-nar stroke and hypertensive patients. Front Aging Neurosci. 2013;5:72. doi: 10.3389/fnagi.2013.00072.
8. Staekenborg SS, Koedam EL, Henneman WJ, Stokman P, Barkhof F, Scheltens P, et al. Progression of mild cognitive impairment to dementia: contribution of cerebrovascular disease compared with medial temporal lobe atrophy. Stroke. 2009;40:1269-1274. doi: 10.1161/STROKEAHA.108.531343.
9. Staekenborg SS, van Straaten EC, van der Flier WM, Lane R, Barkhof F, Scheltens P. Small vessel versus large vessel vascular dementia: risk factors and MRI fndings. J Neurol. 2008;255:1644-1651; discussion 1813. doi: 10.1007/s00415-008-0944-1.
10. Staals J, Makin SD, Doubal FN, Dennis MS, Wardlaw JM. Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden. Neurology. 2014;83:1228-1234. doi: 10.1212/WNL.0000000000000837.
11. Jickling GC, Chen C. Rating total cerebral small-vessel disease: does it add up? Neurology. 2014;83:1224-1225. doi: 10.1212/WNL.0000000000000843.
12. Hilal S, Chai YL, Ikram MK, Elangovan S, Yeow TB, Xu X, et al. Markers of cardiac dysfunction in Cognitive Impairment and Dementia.Medicine.2015;94:e297. doi: 10.1097/MD.0000000000000297.
13. Yeo D, Gabriel C, Chen C, Lee S, Loenneker T, Wong M. Pilot validation of a customized neuropsychological battery in elderly Singaporeans.Neurol J South East Asia. 1997;2:123.
14. American Psychiatric Association. Delirium, Dementia, and Amnestic and Other Cognitive Disorders. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994:133-155.
15. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
16. Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993;43:250-260.
17. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al.; STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1). Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822-838. doi: 10.1016/S1474-4422(13)70124-8.
18. Hilal S, Saini M, Tan CS, Catindig JA, Dong YH, Holandez RL, et al. Intracranial stenosis, cerebrovascular diseases, and cognitive impairment in chinese. Alzheimer Dis Assoc Disord. 2015;29:12-17. doi: 10.1097/WAD.0000000000000045.
19. Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, et al. Pathologic correlates of incidental MRI white matter signal hyper-intensities. Neurology. 1993;43:1683-1689.
20. Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Al-Shahi Salman R, Warach S, et al; Microbleed Study Group. Cerebral micro-bleeds: a guide to detection and interpretation. Lancet Neurol. 2009;8:165-174. doi: 10.1016/S1474-4422(09)70013-4.
21. Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke. 2006;37:2220-2241. doi: 10.1161/01. STR.0000237236.88823.47.
22. Wong A, Xiong YY, Wang D, Lin S, Chu WW, Kwan PW, et al. The NINDS-Canadian stroke network vascular cognitive impairment neu-ropsychology protocols in Chinese. J Neurol Neurosurg Psychiatry. 2013;84:499-504. doi: 10.1136/jnnp-2012-304041.
23. Yu KH, Cho SJ, Oh MS, Jung S, Lee JH, Shin JH, et al; Korean-Vascular Cognitive Impairment Harmonization Standards Study Group. Cognitive impairment evaluated with Vascular Cognitive Impairment Harmonization Standards in a multicenter prospective stroke cohort in Korea. Stroke. 2013;44:786-788. doi: 10.1161/STROKEAHA.112.668343.
24. Wechsler D. Subtest Administration and Scoring. WAIS-IV: Administration and Scoring Manual. San Antonio, TX: The Psychological Corporation;2009;87-93.
25. D'Elia LF, Satz P, Uchiyama CL, White T. Color Trail Test. Color Trails Test. Professional Manual. Odessa, FL: Psychological Assessment Resources; 1996:1-38.
26. Mack WJ, Freed DM, Williams BW, Henderson VW. Boston Naming Test: shortened versions for use in Alzheimer's disease.J Gerontol.1992;47:154-158.
27. Smith A. Symbol Digit Modalities Test. Los Angeles, CA: Services WP; 1973:1-20.
28. Meyers JE, Meyers KR. Rey Complex Figure Test and the Recognition Trial. Odessa, FL: Psychological Assessment Resources; 1994:1-81.
29. Brandt J. The Hopkins Verbal Learning Test: development of a new memory test with six equivalent forms.Clin Neuropsychol.1991;5:125-142.
30. Tham W, Auchus AP, Thong M, Goh M, Chsng H, Wong M, et al. Progression of cognitive impairment after stroke: one year results from a longitudinal study of Singaporean stroke patients.J Neurological Sci.2002;203-204:49-52.
31. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, et al. Development and validation of a geriatric depression screening scale: a preliminary report.J Psychiatr Res.1982-83;17:37-49.
32. Cummings JL. The Neuropsychiatric Inventory: assessing psychopathol-ogy in dementia patients.Neurology.1997;48:10-16.
33. Sachdev PS, Brodaty H, Valenzuela MJ, Lorentz L, Looi JC, Wen W, et al. The neuropsychological prof le of vascular cognitive impairment in stroke and TIA patients.Neurology.2004;62:912-919.
34. Poels MM, Ikram MA, van der Lugt A, Hofman A, Niessen WJ, Krestin G P, et al. Cerebral microbleeds are associated with worse cognitive function: The Rotterdam Scan Study.Neurology.2012;78:326-333.
35. Reed BR, Eberling JL, Mungas D, Weiner M, Kramer JH, Jagust WJ. Effects of white matter lesions and lacunes on cortical function.Arch Neurol.2004;61:1545-1550.
36. Kramer JH, Reed BR, Mungas D, Weiner MW, Chui HC. Executive dysfunction in subcortical ischaemic vascular disease.J Neurol Neurosurg Psychiatry.2002;72:217-220.
37. Inzitari D, Pracucci G, Poggesi A, Carlucci G, Barkhof F, Chabriat H et al. Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoara-iosis and disability) study cohort.BMJ.2009;339: 2477.
38. Brickman AM, Honig LS, Scarmeas N, Tatarina O, Sanders L, Albert MS et al. Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease. Arch Neurol.2008;65:1202-1208. doi: 10.1001/archneur.65.9.1202.
39. Chui HC. Subcortical ischemic vascular dementia.Neurol Clin.2007;25:717-740.
40. Hilal S, Saini M, Tan CS, Catindig JA, Koay WI, Niessen WJ, et al. Cerebral microbleeds and cognition: the epidemiology of dementia in Singapore study.Alzheimer Dis Assoc Disord. 2014;28:106-112. doi: 10.1097/WAD.0000000000000015.
41. Cordonnier C, van der Flier WM. Brain microbleeds and Alzheimer's disease: innocent observation or key player?Brain.2011;134:335-344.
42. Chen YW, Gurol ME, Rosand J, Viswanathan A, Rakich SM, Groover TR, et al. Progression of white matter lesions and hemorrhages in cerebral amyloid angiopathy.Neurology.2006;67:83-87.
43. Arvanitakis Z, Leurgans SE, Wang Z, Wilson RS, Bennett DA, Schneider JA. Cerebral amyloid angiopathy pathology and cognitive domains in older persons. Ann Neurol.2011;69:320-327.